Moderna says bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant
(NEW YORK) -- American biotechnology company Moderna announced Monday that a booster dose of its bivalent COVID-19 vaccine performs better against two circulating versions of the omicron variant, compared with a booster shot of its original formula.The news echoes a similar announcement made earlier... Read More.